tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Glen Santangelo, 205 are a BUY (68.79%), 85 are a HOLD (28.52%), 8 are a SELL (2.68%).
Analyst Glen Santangelo, currently employed at BARCLAYS, carries an average stock price target met ratio of 59.34% that have a potential upside of 23.76% achieved within 234 days.
Glen Santangelo’s has documented 585 price targets and ratings displayed on 55 stocks. The coverage is on Healthcare, Consumer Defensive, Technology, Consumer Cyclical sectors.
Most recent stock forecast was given on BHC, Bausch Health Companies.
Analyst best performing recommendations are on AMRX (AMNEAL PHARMACEUTICALS).
The best stock recommendation documented was for HIMS (HIMS HERS HEALTH) at 2/25/2026. The price target of $25 was fulfilled within 14 days with a profit of $9.18 (58.03%) receiving and performance score of 41.45.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Feb-2018
$215
$40.04 (22.89%)
$187
3 years 3 months 4 days ago
(07-Aug-2023)
15/16 (93.75%)
$28.91 (15.54%)
636
Hold Since 27-May-2022
$190
$15.04 (8.60%)
$176
3 years 3 months 8 days ago
(03-Aug-2023)
12/12 (100%)
$-0.86 (-0.45%)
392
Buy Since 11-Oct-2022
$215
$40.04 (22.89%)
$200
3 years 3 months 8 days ago
(03-Aug-2023)
7/10 (70%)
$24.14 (12.65%)
211
Buy Since 05-Aug-2021
$220
$45.04 (25.74%)
$213
3 years 3 months 8 days ago
(03-Aug-2023)
11/17 (64.71%)
$29.14 (15.27%)
326
$190
$15.04 (8.60%)
3 years 3 months 8 days ago
(03-Aug-2023)
9/9 (100%)
$-0.86 (-0.45%)
440
Which stock is Glen Santangelo most bullish on?
Which stock is Glen Santangelo most reserved on?
What Year was the first public recommendation made by Glen Santangelo?
